G. Heusch

Cardiology and Cardiovascular Medicine · 2000–2020

A researcher in the Science corpus: 9 papers; trusts 4 researchers and is trusted by 10 researchers here, as inferred from the citation graph.

Subfields

Whom G. Heusch trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Yellon
  2. D. Hausenloy
  3. A. Moran
  4. Guido Kroemer
  5. Michael O. Hengartner
  6. Peter Libby
  7. D. Zorov
  8. M. Juhaszova
  9. Gregg Stone

Who trusts G. Heusch overall

  1. Michael R Hamblin
  2. K. Thygesen
  3. Wen Chen
  4. B. J. Gersh
  5. Joseph S. Alpert
  6. S. Cadenas

Papers from G. Heusch's perspective

Ordered by how strongly the researchers G. Heusch trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. (Cardiovascular Research)
  2. Preconditioning the myocardium: from cellular physiology to clinical cardiology. (Physiological Reviews)
  3. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. (The Lancet)
  4. Role of the mitochondrial permeability transition in myocardial disease. (Circulation Research)
  5. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. (New England Journal of Medicine)
  6. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. (New England Journal of Medicine)
  7. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
  8. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) (Critical Care)
  9. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. (The Lancet)
  10. Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning (Pharmacological Reviews)

Their papers